BioNxt Solutions Inc. (BNXTF)
OTCMKTS · Delayed Price · Currency is USD
0.6135
+0.0068 (1.13%)
Sep 29, 2025, 4:00 PM EDT
BioNxt Solutions Market Cap
BioNxt Solutions has a market cap or net worth of $73.85 million as of October 7, 2025. Its market cap has increased by 355.51% in one year.
Market Cap
73.85M
Enterprise Value
78.92M
Revenue
15.88K
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.61
Market Cap Chart
Since August 6, 2019, BioNxt Solutions's market cap has increased from 35.59M to 73.85M, an increase of 107.50%. That is a compound annual growth rate of 12.55%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 6, 2025 | 73.85M | 146.59% |
| Dec 31, 2024 | 29.95M | -24.03% |
| Dec 29, 2023 | 39.42M | -0.85% |
| Dec 30, 2022 | 39.76M | -40.00% |
| Dec 31, 2021 | 66.27M | -27.46% |
| Dec 31, 2020 | 91.36M | 152.18% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Aug 6, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Elite Pharmaceuticals | 674.12M |
| Glass House Brands | 644.95M |
| Veradigm | 511.83M |
| Northwest Biotherapeutics | 380.49M |
| Nika Pharmaceuticals | 333.67M |
| CytoDyn | 321.63M |
| American Oncology Network | 273.17M |
| Silence Therapeutics | 245.14M |